Skip to content
10-Q

Quarterly Report

CardioGenics Holdings Inc.

0001493152-16-008317

← back to feed
Filed
Mar 28, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2016 · Mar 18, 2016 96.05M sh
Shares Diluted Q1 2016 · Jan 31, 2016 116.72M sh
Shares Diluted Q1 2016 · Jan 31, 2015 74.1M sh
Operating Cash Flow Q1 2016 · Jan 31, 2016 $30.06K
Operating Cash Flow Q1 2016 · Jan 31, 2015 −$210.17K
Cash And Equivalents Q1 2016 · Jan 31, 2016 $96.81K
Cash And Equivalents Q1 2016 · Oct 31, 2015 $49.88K
Cash And Equivalents Q1 2016 · Jan 31, 2015 $84.62K
Cash And Equivalents Q1 2016 · Oct 31, 2014 $70.68K
Stockholders Equity Q1 2016 · Jan 31, 2016 −$1.79M
Stockholders Equity Q1 2016 · Oct 31, 2015 −$1.56M
Current Liabilities Q1 2016 · Jan 31, 2016 $2.34M
Current Liabilities Q1 2016 · Oct 31, 2015 $1.79M
Current Assets Q1 2016 · Jan 31, 2016 $385.1K
Current Assets Q1 2016 · Oct 31, 2015 $52.26K
Total Assets Q1 2016 · Jan 31, 2016 $558.45K
Total Assets Q1 2016 · Oct 31, 2015 $231.93K
Sga Expense Q1 2016 · Jan 31, 2016 $138.35K
Sga Expense Q1 2016 · Jan 31, 2015 $133.61K
Rd Expense Q1 2016 · Jan 31, 2016 $59.16K
Rd Expense Q1 2016 · Jan 31, 2015 $67.72K
Net Income Q1 2016 · Jan 31, 2016 −$125.29K
Net Income Q1 2016 · Jan 31, 2015 −$1.06M
Operating Income Q1 2016 · Jan 31, 2016 −$201.1K
Operating Income Q1 2016 · Jan 31, 2015 −$205.7K